Kura Oncology CFO Jennifer Fulk files initial beneficial ownership statement
KURA•Initial Form 3 filing
- Kura Oncology CFO Jennifer Fulk filed an initial Form 3 statement on Sept. 8, 2026.
Related News
Kestra Medical Technologies holds annual shareholder meeting
KMTS•
Arteris CFO Saurabh Sinha files initial beneficial ownership statement
AIP•
iSpecimen gets Nasdaq extension to meet $2.5 million stockholders’ equity rule by Nov. 25
ISPC•
RH Q2 FY26 GAAP net income rises 16.37% to USD 60.2 million; GAAP net revenues increase 2.6% to USD 922.2 million
RH•
Amalgamated Financial EVP, Chief Legal Officer Mandy Tenner disposes of 2,920 common shares worth $142,297.93
AMAL•